D. Ross Camidge
University of Colorado Cancer Center
Affiliation University of Colorado Cancer Center Top Publications Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer (2010) – 4,513 citations Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer (2013) – 3,435 citations Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer (2017) – 2,591 citations Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer (2014) – ... <a title="D. Ross Camidge" class="read-more" href="https://journalsworld.com/researchers/d-ross-camidge/" aria-label="Read more about D. Ross Camidge">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
University of Colorado Cancer Center
Top Publications
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer (2010) - 4,513 citations
- Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer (2013) - 3,435 citations
- Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer (2017) - 2,591 citations
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer (2014) - 2,018 citations
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs (2014) - 1,766 citations
At a glance
- Full name
- D. Ross Camidge
- ORCID
- 0000-0003-3430-3213
- OpenAlex ID
- https://openalex.org/A5082517668
Research interests
- Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer ↗2010 · New England Journal of Medicine4,513OpenAlex citations
- Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer ↗2013 · New England Journal of Medicine3,435OpenAlex citations
- Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer ↗2017 · New England Journal of Medicine2,591OpenAlex citations
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer ↗2014 · New England Journal of Medicine2,018OpenAlex citations
- 1,766OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer ↗2010 · New England Journal of Medicine
- Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer ↗2013 · New England Journal of Medicine
- Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer ↗2017 · New England Journal of Medicine
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer ↗2014 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 23:01:55
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.